COMP is Selectively Up-regulated in Degenerating Acinar Cells in Chronic Pancreatitis and in Chronic-Pancreatitis-like Lesions in Pancreatic Cancer

Background: Chronic pancreatitis (CP) is an inflammatory disease of the pancreas characterized histomorphologically by progressive development of fibrosis and atrophy of the pancreatic parenchyma. Cartilage oligomeric matrix protein (COMP) is a member of the thrombospondin (TSP) family of extracellular glycoproteins that is expressed in CP tissues. In the present study, we characterized COMP mRNA and protein expression in the normal pancreas, chronic pancreatitis, and pancreatic cancer tissues. Methods: 15 normal pancreatic tissues, 14 CP tissues and 14 pancreatic cancer tissues were analyzed by Northern blotting, Western blotting, in situ hybridization and immunohistochemistry. Results: COMP mRNA and protein were detected at moderate to high levels in chronic pancreatitis tissues, at moderate levels in pancreatic cancer tissues, but at low levels in normal pancreatic tissues and in four pancreatic cancer cell lines. COMP mRNA signals and immunoreactivity were strongly present in the cytoplasm of degenerating acinar cells in CP tissues as well as in CP-like lesions in pancreatic cancer tissues. COMP protein was also present in the fibrotic tissue in CP. In contrast, COMP expression was weak to absent in the cytoplasm of cancer cells in pancreatic cancer tissues, and in ductal cells and islet cells in normal pancreatic tissues. Conclusion: COMP is preferentially expressed in degenerating acinar cells in CP and in CP-like areas in pancreatic cancer, suggesting a potential role of this gene in the course of acinar cell degeneration and dedifferentiation. COMP might thus serve as a marker for tissue destruction and disease activity in CP.

[1]  R. Schmid,et al.  Chronic pancreatitis: still puzzling? , 1997, Gastroenterology.

[2]  P. Malfertheiner,et al.  Immunopathogenesis of chronic pancreatitis. , 1998, Gastroenterology.

[3]  K. Daniels,et al.  Identification of twelve mutations in cartilage oligomeric matrix protein (COMP) in patients with pseudoachondroplasia. , 1998, American journal of medical genetics.

[4]  W. Cole,et al.  Multiple epiphyseal dysplasia and pseudoachondroplasia due to novel mutations in the calmodulin‐like repeats of cartilage oligomeric matrix protein , 1997, Clinical genetics.

[5]  S. Jimenez,et al.  Production of cartilage oligomeric matrix protein (COMP) by cultured human dermal and synovial fibroblasts. , 1998, Osteoarthritis and cartilage.

[6]  A. Olsen,et al.  Pseudoachondroplasia and multiple epiphyseal dysplasia due to mutations in the cartilage oligomeric matrix protein gene , 1995, Nature Genetics.

[7]  H. Sarles,et al.  Pathogenesis and epidemiology of chronic pancreatitis. , 1989, Annual review of medicine.

[8]  J. Lawler,et al.  Cartilage Oligomeric Matrix Protein Is a Calcium-binding Protein, and a Mutation in Its Type 3 Repeats Causes Conformational Changes* , 2000, The Journal of Biological Chemistry.

[9]  Yusuke Nakamura,et al.  Novel and recurrent COMP (cartilage oligomeric matrix protein) mutations in pseudoachondroplasia and multiple epiphyseal dysplasia , 1998, Human Genetics.

[10]  K. Daniels,et al.  Identification of nine novel mutations in cartilage oligomeric matrix protein in patients with pseudoachondroplasia and multiple epiphyseal dysplasia. , 1999, American journal of medical genetics.

[11]  M. Fenchel,et al.  Cartilage Oligomeric Matrix Protein (Thrombospondin-5) Is Expressed by Human Vascular Smooth Muscle Cells , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[12]  D. Heinegård,et al.  Distribution and expression of cartilage oligomeric matrix protein and bone sialoprotein show marked changes during rat femoral head development. , 1995, Matrix biology : journal of the International Society for Matrix Biology.

[13]  D Heinegård,et al.  Up-regulation of cartilage oligomeric matrix protein at the onset of articular cartilage degeneration in a transgenic mouse model of osteoarthritis. , 2000, Arthritis and rheumatism.

[14]  S. Gansauge,et al.  Altered expression of extracellular matrix molecules and their receptors in chronic pancreatitis and pancreatic adenocarcinoma in comparison with normal pancreas , 1995, International journal of pancreatology : official journal of the International Association of Pancreatology.

[15]  M. Paulsson,et al.  Cartilage oligomeric matrix protein (COMP) is an abundant component of tendon , 1994, FEBS letters.

[16]  E. Dimagno.  A short, eclectic history of exocrine pancreatic insufficiency and chronic pancreatitis. , 1993, Gastroenterology.

[17]  D. Glavač,et al.  Evidence that hereditary pancreatitis is genetically heterogeneous disorder , 2000, Pflügers Archiv.

[18]  H. Friess,et al.  Balance of expression of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in chronic pancreatitis. , 1994, Zeitschrift fur Gastroenterologie.

[19]  G. Newton,et al.  Characterization of human and mouse cartilage oligomeric matrix protein. , 1994, Genomics.

[20]  P. Malfertheiner,et al.  Assessment of the fibrogenetic activity in chronic pancreatitis , 1993, International journal of pancreatology : official journal of the International Association of Pancreatology.

[21]  G. Mortier,et al.  Diverse mutations in the gene for cartilage oligomeric matrix protein in the pseudoachondroplasia-multiple epiphyseal dysplasia disease spectrum. , 1998, American journal of human genetics.

[22]  J Engel,et al.  Electron microscopy of native cartilage oligomeric matrix protein purified from the Swarm rat chondrosarcoma reveals a five-armed structure. , 1992, The Journal of biological chemistry.

[23]  H. Friess,et al.  Enhanced expression of transforming growth factor β isoforms in pancreatic cancer correlates with decreased survival , 1993 .

[24]  T. Seufferlein,et al.  Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation. , 2001, Cancer research.

[25]  James D. Evans,et al.  Chronic pancreatitis and pancreatic carcinoma. , 1997, Postgraduate medical journal.

[26]  D. Heinegård,et al.  Cartilage matrix proteins. An acidic oligomeric protein (COMP) detected only in cartilage. , 1992, The Journal of biological chemistry.

[27]  H. Friess,et al.  Identification of Disease-specific Genes in Chronic Pancreatitis Using DNA Array Technology , 2001, Annals of surgery.

[28]  E. Thonar,et al.  Characterization of monoclonal antibodies recognizing different fragments of cartilage oligomeric matrix protein in human body fluids. , 1997, Archives of biochemistry and biophysics.

[29]  L. Li,et al.  Transdifferentiation of neoplastic cells. , 2001, Medical hypotheses.

[30]  P. Lankisch.  [Chronic pancreatitis]. , 1991, Der Internist.

[31]  H. Sarles,et al.  Pancreatic Extracellular Matrix Alterations in Chronic Pancreatitis , 1987, Pancreas.

[32]  D. Heinegård,et al.  Cartilage Oligomeric Matrix Protein Shows High Affinity Zinc-dependent Interaction with Triple Helical Collagen* , 1998, The Journal of Biological Chemistry.

[33]  M. Paulsson,et al.  Cartilage oligomeric matrix protein and thrombospondin 1. Purification from articular cartilage, electron microscopic structure, and chondrocyte binding. , 1994, European journal of biochemistry.

[34]  D. Heinegård,et al.  The distribution of cartilage oligomeric matrix protein (COMP) in tendon and its variation with tendon site, age and load. , 1997, Matrix biology : journal of the International Society for Matrix Biology.

[35]  M. Löhr,et al.  Release of Hyaluronan and Laminin into Pancreatic Secretions , 1999, Digestion.

[36]  H. Friess,et al.  The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer. , 1998, The Journal of clinical investigation.

[37]  D. Heinegård,et al.  COMP (cartilage oligomeric matrix protein) is structurally related to the thrombospondins. , 1992, The Journal of biological chemistry.

[38]  K. Kadler,et al.  Cartilage Oligomeric Matrix Protein Interacts with Type IX Collagen, and Disruptions to These Interactions Identify a Pathogenetic Mechanism in a Bone Dysplasia Family* , 2001, The Journal of Biological Chemistry.

[39]  J. Braganza.  A Framework for the Aetiogenesis of Chronic Pancreatitis , 1998, Digestion.